Su X, Lin Q, Liu B, Zhou C, Lu L, Lin Z
Cell Insight. 2025; 4(2):100229.
PMID: 39995512
PMC: 11849079.
DOI: 10.1016/j.cellin.2025.100229.
Zheng Z, Zhou C, Yi F, Li J
Am J Cancer Res. 2025; 15(1):1-18.
PMID: 39949926
PMC: 11815388.
DOI: 10.62347/EHQK5961.
Caprifico A, Vaghi L, Spearman P, Calabrese G, Papagni A
BMC Med Imaging. 2024; 24(1):316.
PMID: 39567942
PMC: 11580358.
DOI: 10.1186/s12880-024-01488-x.
Murmu A, Gyorffy B
Front Med. 2024; 18(5):778-797.
PMID: 39115792
DOI: 10.1007/s11684-024-1085-3.
Tofigh P, Mirghazanfari S, Hami Z, Nassireslami E, Ebrahimi M
Rep Biochem Mol Biol. 2024; 12(4):596-608.
PMID: 39086589
PMC: 11288232.
DOI: 10.61186/rbmb.12.4.596.
Relevance of blood tumor markers in inpatients with significant involuntary weight loss and elevated levels of inflammation biomarkers.
Gronnier M, Hedhli K, Sauzay C, Salle V, Duhaut P, Schmidt J
BMC Cancer. 2024; 24(1):468.
PMID: 38622530
PMC: 11017702.
DOI: 10.1186/s12885-024-12201-0.
NXPH4 can be used as a biomarker for pan-cancer and promotes colon cancer progression.
Zhang Z, Wang P, Chen S, Xiang D, Chen J, Huang W
Aging (Albany NY). 2024; 16(7):5866-5886.
PMID: 38613793
PMC: 11042927.
DOI: 10.18632/aging.205648.
The molecular characteristics could supplement the staging system of pT2/T3N0M0 esophageal squamous cell carcinoma: a translational study based on a cohort with over 20 years of follow-up.
Jiang W, Tian J, Guo Y, Qiu L, Luo X, Huang Y
Cancer Cell Int. 2024; 24(1):119.
PMID: 38553712
PMC: 10981364.
DOI: 10.1186/s12935-024-03286-5.
Immunohistochemistry for Cancer Stem Cell Detection: Principles and Methods.
Zannini G, Franco R, Marino F
Methods Mol Biol. 2024; 2777:19-33.
PMID: 38478333
DOI: 10.1007/978-1-0716-3730-2_2.
T790M mutation upconversion fluorescence biosensor via mild ATRP strategy and site-specific DNA cleavage of restriction endonuclease.
Liu Y, Guo L, Hou M, Gao H, Ke Y, Yang H
Mikrochim Acta. 2024; 191(3):148.
PMID: 38374311
DOI: 10.1007/s00604-024-06229-z.
Pleural Uptake Patterns in Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) Scans Improve the Identification of Malignant Pleural Effusions.
Cohen S, Betancourt J, Soo Hoo G
J Clin Med. 2023; 12(22).
PMID: 38002592
PMC: 10672363.
DOI: 10.3390/jcm12226977.
SRSF7 is a promising prognostic biomarker in hepatocellular carcinoma and is associated with immune infiltration.
Shen W, Yuan L, Cheng F, Wu Z, Li X
Genes Genomics. 2023; 46(1):49-64.
PMID: 37985547
DOI: 10.1007/s13258-023-01463-w.
Identification of Novel Diagnostic and Prognostic Gene Signature Biomarkers for Breast Cancer Using Artificial Intelligence and Machine Learning Assisted Transcriptomics Analysis.
Mirza Z, Ansari M, Iqbal M, Ahmad N, Alganmi N, Banjar H
Cancers (Basel). 2023; 15(12).
PMID: 37370847
PMC: 10296674.
DOI: 10.3390/cancers15123237.
Spice-Derived Bioactive Compounds Confer Colorectal Cancer Prevention via Modulation of Gut Microbiota.
Dacrema M, Ali A, Ullah H, Khan A, Di Minno A, Xiao J
Cancers (Basel). 2022; 14(22).
PMID: 36428774
PMC: 9688386.
DOI: 10.3390/cancers14225682.
Drug-Loaded Acoustic Nanodroplet for Dual-Imaging Guided Highly Efficient Chemotherapy Against Nasopharyngeal Carcinoma.
Yang D, Chen Q, Zhang M, Feng G, Sun D, Lin L
Int J Nanomedicine. 2022; 17:4879-4894.
PMID: 36262190
PMC: 9576276.
DOI: 10.2147/IJN.S377514.
Mitochondrial Homeostasis-Related lncRNAs are Potential Biomarkers for Predicting Prognosis and Immune Response in Lung Adenocarcinoma.
Peng B, Lou H, Chen C, Wang L, Li H, Lu T
Front Genet. 2022; 13:870302.
PMID: 35769997
PMC: 9234294.
DOI: 10.3389/fgene.2022.870302.
Integrated Bioinformatics Analysis for Identifying the Significant Genes as Poor Prognostic Markers in Gastric Adenocarcinoma.
Li Y, Luo Y, Tian Q, Lai Y, Xu L, Yun H
J Oncol. 2022; 2022:9080460.
PMID: 35726219
PMC: 9206555.
DOI: 10.1155/2022/9080460.
Diagnostic Accuracy of Salivary Biomarkers in Detecting Early Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Shaw A, Garcha V, Shetty V, Vinay V, Bhor K, Ambildhok K
Asian Pac J Cancer Prev. 2022; 23(5):1483-1495.
PMID: 35633529
PMC: 9587865.
DOI: 10.31557/APJCP.2022.23.5.1483.
A novel prognostic signature based on four glycolysis-related genes predicts survival and clinical risk of hepatocellular carcinoma.
Chen Z, Zou Y, Zhang Y, Chen Z, Wu F, Shi N
J Clin Lab Anal. 2021; 35(11):e24005.
PMID: 34523732
PMC: 8605142.
DOI: 10.1002/jcla.24005.
TNM staging towards a personalized approach in metastatic urothelial carcinoma: what will the future be like?-a narrative review.
Rizzo A, Mollica V, Cimadamore A, Santoni M, Scarpelli M, Schiavina R
Transl Androl Urol. 2021; 10(3):1541-1552.
PMID: 33850788
PMC: 8039595.
DOI: 10.21037/tau-20-1109.